Abstract:BACKGROUND:Emerging evidence indicates the importance of heparan sulfate 6-O-sulfotransferase 2 (HS6ST2) in a number of developmental processes. Little is known regarding its biological function in regulating cervical cancer (CC) progression. In this study, we aim to explore the role of HS6ST2 in CC progression.METHODS:The transcriptome sequencing data of CC tissues from three databases, GSE64217, GSE138080, and GSE63514, was examined for genes with significant changes. The expression profile for HS6ST2 within CC tissue was then assessed through fluorescence quantitative PCR and immunohistochemistry and compared to data from patients with clinicopathological features. A multivariate survival analysis was performed using the COX regression. The real-time quantitative PCR assessed the HS6ST2 expression profile within CC cellular cultures. The results of knocking down HS6ST2, considering the proliferative activity and invasiveness of CC cultures in vitro, were detected through cell viability assay, clonogenic assessment, tumorsphere formation analysis, 3D invasion experiment and transwell assay. The impact of HS6ST2 knockdown in CC proliferation was also evaluated in vivo using a nude mice model.RESULTS:HS6ST2 was severely upregulated within CC tissues across the three explored databases (GSE64217, GSE138080, and GSE63514). Fluorescent quantitative PCR and immunohistochemistry experiments identified HS6ST2 as highly upregulated within patients CC tissues. Survival analysis taking into account the parameters of lymph node metastasis, Federation of Gynecology and Obstetrics (FIGO) stage, depth of invasion, pathological grade, and HS6ST2 expression level demonstrated that individuals with downregulated HS6ST2 exhibited considerably extended progression-free survival (PFS) and overall survival (OS) in comparison to upregulated HS6ST2 cases. According to the findings of COX univariate analysis, the parameters lymph node metastasis, FIGO stage, depth of invasion, pathological grade, and HS6ST2 expression level, all showed a statistically significant correlation with effect upon prognosis of CC patients. The FIGO stage, depth of invasion and expression level of HS6ST2 were identified as independent risk variables influencing CC case prognosis within subsequent COX multivariate analysis. Cell function experiments proved that HS6ST2 knockdown can considerably diminish the proliferative potential, stemness and invasive traits of CC cells. Tumor formation experiments in nude mice in vivo demonstrated that knocking down HS6ST2 can significantly thwart CC cellular proliferative properties within animal models.CONCLUSIONS:The clinicopathological features and the survival time of the patients significantly correlate with the level of HS6ST2 expression in CC tissue samples.

Function of Hes6 an Inhibitor of Hes1, in the Breast Cancer Cell Lines T47d and Mcf-7 is to Up-Regulate E2f-1 and Increased Proliferation

Hes-6, an Inhibitor of Hes-1, is Regulated by 17Β-Estradiol and Promotes Breast Cancer Cell Proliferation

Human Homolog of Drosophila Hairy and Enhancer of Split 1, Hes1, Negatively Regulates Δ-Catenin (CTNND2) Expression in Cooperation with E2F1 in Prostate Cancer

Upregulation of HES1 Promotes Cell Proliferation and Invasion in Breast Cancer As a Prognosis Marker and Therapy Target Via the AKT Pathway and EMT Process

HES1 Overexpression Promotes Cell Proliferation and Invasion in Breast Cancer and Predicts Poor Survival

Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer.

Up-Regulated Hyaluronan Synthase 2 Mediates Epidermal Growth Factor-Induced Cell Migration and Invasion in Human Endometriotic Stromal Cells.

Hes1 Promotes Cell Proliferation And Migration By Activating Bmi-1 And Pten/Akt/Gsk3 Beta Pathway In Human Colon Cancer

Hes1/Hes5 Gene Inhibits Differentiation Via Down-Regulating Hash1 And Promotes Proliferation In Cervical Carcinoma Cells

HES1 promotes breast cancer stem cells by elevating Slug in triple-negative breast cancer

HES1 Promotes Metastasis and Predicts Poor Survival in Patients with Colorectal Cancer

The HOXB7 Protein Renders Breast Cancer Cells Resistant to Tamoxifen Through Activation of the EGFR Pathway.

Homeobox A7 Stimulates Breast Cancer Cell Proliferation by Up-Regulating Estrogen Receptor-Alpha

Downregulation of HS6ST2 Inhibits Cervical Cancer Cell Migration and Invasion in Vivo and in Vitro.

Prognostic Significance of Hes-1, a Downstream Target of Notch Signaling in Hepatocellular Carcinoma.

HES5 Promotes Cellular Proliferation of Non-Small Cell Lung Cancer Through STAT3 Signaling

HES6 Mediates Oxidative Phosphorylation Pathway to Promote Immune Infiltration of CD8 + T Cells in Lung Adenocarcinoma

HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins

Data from Hoxb7 Inhibits Transgenic HER-2/neu–Induced Mouse Mammary Tumor Onset but Promotes Progression and Lung Metastasis

Transmembrane 4 L Six Family Member 1 Suppresses Hormone Receptor-–Positive, HER2-Negative Breast Cancer Cell Proliferation

Heparanase Promotes Radiation Resistance of Cervical Cancer by Upregulating Hypoxia Inducible Factor 1